Alvotech And Advanz Celebrate EU Omalizumab Filing

Kashiv-Partnered Xolair Biosimilar Accepted For Review By EMA

 
• By Dave Wallace
  
European Medicines Agency Sign Amsterdam
The EMA has accepted the omalizumab biosimilar filing • Source: Alamy

More from Biosimilars

More from Products